ISRG - インテュイティブ・サ―ジカル (Intuitive Surgical Inc.)

ISRGのニュース

   Is Intuitive Surgical Stock a Buy?  2020/07/21 11:33:00 The Motley Fool
Can the company overcome the troubles it has encountered recently?
   Thinking about trading options or stock in Dynavax Technologies, Vaxart Inc, Intuitive Surgical, Ford Motor, or Southwest Airlines?  2020/07/20 13:31:00 PR Newswire
NEW YORK, July 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DVAX, VXRT, ISRG, F, and LUV. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…
   Global Bariatric Surgery Market (2019 to 2028) - Featuring Apollo Endosurgery, Allergan & Intuitive Surgical Among Others - ResearchAndMarkets.com  2020/06/26 09:28:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Bariatric Surgery Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global bariatric surgery market is estimated to grow with a CAGR of 9.41% in the forecasting period 2019-2028. The growing prevalence of diabetes and cardiac diseases is the main factor driving the growth of the global bariatric surgery market. The escalating obesity rate across the world is also aiding the global market growth. However, lack of awareness amon
   A fund manager crushing 98% of his peers over the past half-decade told us 5 themes he's betting on and 4 he's betting against — and why the latest market rally still has room to run  2020/06/10 12:03:00 Business Insider
Mitch Rubin runs a mutual fund that's riding a combination of long and short positions to a 26% gain so far this year. Rubin told Business Insider about the key themes that are contributing to the gains in the long part of his portfolio and the kinds of stocks he's successfully bet against. Even though markets have staged a historic rally, Rubin says he's shorting fewer stocks than usual because there is still a lot of room for them to rise as the economy improves. Click here to sign up for our weekly newsletter, Investing Insider. Visit Business Insider's homepage for more stories . Very few stock pickers on Wall Street can say they're having a better year than usual. Mitch Rubin of RiverPark Ventures is one of those few. He made money by betting on big tech and against energy companies. And when the novel coronavirus started spreading beyond China, he made money betting against travel and entertainment companies. Add it up and Rubin's RiverPark Long/Short Opportunity Fund has returned 26% to investors in a year when the market is roughly flat and most funds of its class are negative.
   How a nonprofit you’ve never heard of made the web safer for everyone  2020/04/24 06:00:54 Fast Company
By making encryption free and easy, Let’s Encrypt solved one of the web’s biggest problems. Its secret? A maniacal focus on automation and efficiency. Let’s Encrypt issued its one billionth digital certificate a few weeks ago. Run by the nonprofit Internet Security Research Group (ISRG), the service provides these certificates to websites for free, allowing your browser to create a secure and validated connection to a server that’s effectively impenetrable to snooping. The pandemic hasn’t halted the group’s progress: It says it’s now issued over 1,080,000,000 certificates. Read Full Story
   Global Bariatric Surgery Market (2019 to 2028) - Featuring Apollo Endosurgery, Allergan & Intuitive Surgical Among Others - ResearchAndMarkets.com  2020/06/26 09:28:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Bariatric Surgery Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global bariatric surgery market is estimated to grow with a CAGR of 9.41% in the forecasting period 2019-2028. The growing prevalence of diabetes and cardiac diseases is the main factor driving the growth of the global bariatric surgery market. The escalating obesity rate across the world is also aiding the global market growth. However, lack of awareness amon
   A fund manager crushing 98% of his peers over the past half-decade told us 5 themes he's betting on and 4 he's betting against — and why the latest market rally still has room to run  2020/06/10 12:03:00 Business Insider
Mitch Rubin runs a mutual fund that's riding a combination of long and short positions to a 26% gain so far this year. Rubin told Business Insider about the key themes that are contributing to the gains in the long part of his portfolio and the kinds of stocks he's successfully bet against. Even though markets have staged a historic rally, Rubin says he's shorting fewer stocks than usual because there is still a lot of room for them to rise as the economy improves. Click here to sign up for our weekly newsletter, Investing Insider. Visit Business Insider's homepage for more stories . Very few stock pickers on Wall Street can say they're having a better year than usual. Mitch Rubin of RiverPark Ventures is one of those few. He made money by betting on big tech and against energy companies. And when the novel coronavirus started spreading beyond China, he made money betting against travel and entertainment companies. Add it up and Rubin's RiverPark Long/Short Opportunity Fund has returned 26% to investors in a year when the market is roughly flat and most funds of its class are negative.
   How a nonprofit you’ve never heard of made the web safer for everyone  2020/04/24 06:00:54 Fast Company
By making encryption free and easy, Let’s Encrypt solved one of the web’s biggest problems. Its secret? A maniacal focus on automation and efficiency. Let’s Encrypt issued its one billionth digital certificate a few weeks ago. Run by the nonprofit Internet Security Research Group (ISRG), the service provides these certificates to websites for free, allowing your browser to create a secure and validated connection to a server that’s effectively impenetrable to snooping. The pandemic hasn’t halted the group’s progress: It says it’s now issued over 1,080,000,000 certificates. Read Full Story
   Intuitive Surgical's Coronavirus Slump Is Likely to Be Brief | The Motley Fool  2020/04/21 19:23:00 The Motley Fool
“Elective” surgeries can only be delayed for so long.
   Intuitive Surgical (ISRG) Q1 Earnings Beat Estimates, Up Y/Y  2020/04/17 11:18:00 Zacks Investment Research
Intuitive Surgical (ISRG) first-quarter results benefit from strong growth across all businesses and higher revenues.
   What's in the Cards for Intuitive Surgical (ISRG) Q4 Earnings?  2020/01/20 07:41:00 Zacks Investment Research
Better-than-expected performance at Instruments & Accessories segment and da Vince procedure growth are likely to have benefited Intuitive Surgical's (ISRG) Q4 earnings.
   Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results  2020/01/10 13:13:15 Zacks Investment Research
Higher revenues and growth in worldwide da Vinci procedure volume benefit Intuitive Surgical's (ISRG) preliminary Q4 results.
   Stocks making the biggest moves after the bell: KB Home, Intuitive Surgical, NortonLifeLock and more  2020/01/09 23:06:44 CNBC
Take a look at the companies making headlines after the bell.
   Here's Why You Should Hold on to Intuitive Surgical for Now  2019/12/31 06:49:00 Zacks Investment Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.
   The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares  2019/12/26 12:55:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) DURECT Corporation (NASDAQ: DRRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Exagen Inc (NASDAQ: XGN ) Forty Seven Inc (NASDAQ: FTSV ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) (JPMorgan initiated coverage with an Outperform rating) Microbot Medical Inc (NASDAQ: MBOT ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc.

calendar